Brussels: The European Commission has quietly buried one of the Green Deal’s most ambitious promises. After years of drafting, it confirmed in spring 2026 that it will not reopen REACH, the sprawling regulation that governs how tens of thousands of chemicals are registered, tested and restricted across the Union. Environment Commissioner Jessica Roswall told lawmakers the conclusion was blunt: not now.
REACH has anchored European chemical safety since 2007, and campaigners had waited most of a decade for a revision that would tighten rules on hormone disruptors, ban harmful substances in groups rather than one by one, and force more data from industry. The revision had already slipped repeatedly before the Commission set it aside for the remainder of its mandate.
Competitiveness trumps overhaul
The reasoning is economic. Europe’s chemical makers face high energy prices, softening demand and fierce competition from American and Asian rivals, and Germany, home to the continent’s largest producers, warned in early 2026 that reopening REACH would carry negative repercussions for competitiveness. Ministers feared that years of legislative uncertainty would freeze investment precisely when the sector could least afford it. The politics of the moment favour factories over fresh rules.
Rather than rewrite the law, the Commission reaches for lighter tools. Its Chemicals Industry Action Plan pairs targeted enforcement with a simplification omnibus, the sixth such package of this mandate, meant to streamline existing chemicals legislation and shore up the finances of the European Chemicals Agency. Officials estimate the changes will save industry at least 363 million euros a year, a figure that tells you where the priority now sits.
What gets lost, and what does not
Health and environment groups see a retreat dressed as pragmatism. Grouping restrictions, the idea of banning whole families of related chemicals at once, was meant to stop manufacturers swapping one problem substance for a barely different cousin, a practice regulators struggle to chase molecule by molecule. Without a legislative revision, that reform stalls, and the toughest questions about persistent pollutants and endocrine disruptors fall to slower administrative channels.
The counter-argument deserves a hearing. Simplification is not the same as deregulation, and the substances already banned or restricted under REACH stay banned. The Commission insists it can modernise through comitology, the technical rule-making that adjusts the law’s annexes without a full reopening, and that stronger enforcement of existing duties may protect more people than a grand rewrite stuck in negotiation for years. On this reading, a working law enforced beats a perfect law delayed.
Both sides are partly right, and that is the discomfort. Europe has genuinely fallen behind on industrial competitiveness, and a chemicals sector in retreat would weaken everything from batteries to pharmaceuticals that depends on it. Yet the same continent built its reputation on the precautionary principle, and shelving REACH signals that the principle now yields when growth is on the line.
The decision fits a wider pattern. Across files from sustainability reporting to due diligence, the Commission has spent this mandate trimming the rules it wrote in greener years, recasting the Green Deal’s ambitions in the language of competitiveness. Whether that rebalancing protects European industry or merely postpones the reckoning over toxic chemicals will not be clear for years. For now, the message from Brussels is that the overhaul can wait, and that the burden of proof has shifted from the polluter to the regulator.
